BICYCLE THERAPEUTICS PLC financial data

Symbol
BCYC on Nasdaq
Location
Cambridge, United Kingdom
Fiscal year end
31 December
Latest financial report
17 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1179% % -17%
Debt-to-equity 21% % -14%
Return On Equity -33% % -40%
Return On Assets -27% % -44%
Operating Margin -340% % 43%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 69,367,896 shares 0.44%
Entity Public Float $266,666,552 USD -65%
Common Stock, Value, Issued $894,000 USD 0.45%
Weighted Average Number of Shares Outstanding, Basic 69,279,838 shares 19%
Weighted Average Number of Shares Outstanding, Diluted 69,279,838 shares 19%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $72,586,000 USD 106%
Research and Development Expense $240,283,000 USD 39%
General and Administrative Expense $79,368,000 USD 10%
Operating Income (Loss) $247,065,000 USD -18%
Nonoperating Income (Expense) $28,257,000 USD -22%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $218,808,000 USD -26%
Income Tax Expense (Benefit) $152,000 USD
Net Income (Loss) Attributable to Parent $218,960,000 USD -30%
Earnings Per Share, Basic -3.16 USD/shares -9%
Earnings Per Share, Diluted -3.16 USD/shares -9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $628,110,000 USD -29%
Accounts Receivable, after Allowance for Credit Loss, Current $0 USD
Assets, Current $682,885,000 USD -26%
Property, Plant and Equipment, Net $6,021,000 USD -37%
Operating Lease, Right-of-Use Asset $15,886,000 USD 107%
Other Assets, Noncurrent $12,805,000 USD 16%
Assets $717,597,000 USD -25%
Accounts Payable, Current $9,669,000 USD -39%
Employee-related Liabilities, Current $17,000,000 USD 4.5%
Accrued Liabilities, Current $44,354,000 USD 7.5%
Liabilities, Current $56,984,000 USD -15%
Operating Lease, Liability, Noncurrent $14,096,000 USD 253%
Other Liabilities, Noncurrent $1,032,000 USD -7.9%
Liabilities $107,620,000 USD -34%
Accumulated Other Comprehensive Income (Loss), Net of Tax $3,505,000 USD -3045%
Retained Earnings (Accumulated Deficit) $899,751,000 USD -32%
Stockholders' Equity Attributable to Parent $609,977,000 USD -23%
Liabilities and Equity $717,597,000 USD -25%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $86,370,000 USD -22%
Net Cash Provided by (Used in) Financing Activities $41,000 USD -102%
Net Cash Provided by (Used in) Investing Activities $604,000 USD -4933%
Common Stock, Shares Authorized 159,685,229 shares 2.4%
Common Stock, Shares, Issued 69,367,896 shares 0.44%
Common Stock, Par or Stated Value Per Share 0.01 GBP/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $86,547,000 USD -25%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $628,715,000 USD -29%
Interest Paid, Excluding Capitalized Interest, Operating Activities $686,000 USD 1%
Deferred Tax Assets, Valuation Allowance $126,761,000 USD 27%
Deferred Tax Assets, Gross $141,894,000 USD 27%
Operating Lease, Liability $16,647,000 USD 79%
Depreciation $6,600,000 USD 12%
Payments to Acquire Property, Plant, and Equipment $604,000 USD 4933%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $222,584,000 USD -33%
Property, Plant and Equipment, Gross $28,193,000 USD 0.64%
Operating Lease, Liability, Current $2,551,000 USD -52%
Lessee, Operating Lease, Liability, to be Paid, Year Two $2,874,000 USD -14%
Lessee, Operating Lease, Liability, to be Paid, Year One $3,463,000 USD -40%
Operating Lease, Weighted Average Discount Rate, Percent 0.064 pure -18%
Deferred Income Tax Expense (Benefit) $1,316,000 USD -72%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $3,167,000 USD 390%
Lessee, Operating Lease, Liability, to be Paid, Year Three $3,654,000 USD 345%
Deferred Tax Assets, Operating Loss Carryforwards $101,324,000 USD 24%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $3,654,000 USD
Operating Lease, Payments $1,454,000 USD 1.3%
Additional Paid in Capital $1,512,339,000 USD 2.7%
Depreciation, Depletion and Amortization $1,634,000 USD -1.4%
Share-based Payment Arrangement, Expense $39,464,000 USD 3.6%
Interest Expense $3,276,000 USD -1.7%